Top tier investor Orbimed discloses 8.4% stake in new IPO Sionna Therapeutics; An overview from an SA analyst $SION
In a filing late last week, top-tier investor Orbimed Advisors disclosed an 8.4% stake in Sionna Therapeutics $SION (market cap: $850m) (SEC filing). $SION went public a few weeks ago (Link). They're developing Cystic Fibrosis treatments. Other top tier investors are also involved. Here's a look at the company in advance of its recent IPO:
- Sionna Therapeutics Seeks $100 Million in IPO For Cystic Fibrosis Treatments
Posted Feb 17, 2025, 5:25 PM UTC
30